Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Jan 20, 2021

Dr. Charles Keller, Scientific Director, Children's Cancer Therapy Development Institute is working with a diverse team in this non-profit biotech to make all childhood cancers universally survivable.  Filling the preclinical gap, cc-TDI is moving drugs for pediatric brain tumors and muscle cancers into national clinical trials. Charles also sheds light on the incentives and obligations legislated in the Creating Hope Act that insures childhood cancers though rare, are given the same consideration for study as adult cancers. 

@cctdilab #childhoodcancer #pediatriccancer #cancer #braintumor

cc-TDI.org

Listen to the podcast here

cc-TDI